This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Antibiotics


  • Unusual Antibiotics Show Promise Against Deadly Superbugs
    An unusual type of antibiotic being developed by chemists at Notre Dame University shows promise in defeating deadly superbugs -- highly drug-resistant staph bacteria that are an increasing source of hospital-based infections. The novel antibiotics, which could some day ...More
    August 29, 2005 Posted in News
  • Overcoming Drug Resistance
    Researchers at the University of Alabama at Birmingham (UAB) and Ohio State University have taken a major step in the battle against drug-resistant bacteria. New findings published in the journal Cell show for the first time a mechanism of how rifamycins, a family of ...More
    August 22, 2005 Posted in News
  • FDA Announces Final Decision About Antimicrobial Drug Used to Treat Bacterial Infections in Poultry
    Food and Drug Administration (FDA) Commissioner Lester Crawford announces the agency's final decision to no longer allow distribution or use of the antimicrobial drug enrofloxacin for the purpose of treating bacterial infections in poultry. This ruling does not affect other ...More
    July 29, 2005 Posted in News
  • Quality Measures Need to be Field-Tested, Researchers Find
    ALEXANDRIA, Va. -- A group of researchers has developed a set of "quality indicators" to measure the quality of antibiotic use in hospitalized patients with lower respiratory tract infections (LRTIs) by combining scientific evidence with expert opinion, according to an ...More
    July 26, 2005 Posted in News
  • Hospira Ships First Orders of Ceftriaxone Injection
    LAKE FOREST, Ill. -- Hospira, Inc. announced today that it has shipped the first customer orders of the company's generic ceftriaxone for injection, USP. The medication is the generic version of Roche Pharmaceuticals' Rocephin, the world's leading injectable antibiotic, ...More
    July 20, 2005 Posted in News
  • Research Shows Topical Silver as an Effective Defense Against Growing MRSA Threat
    PORTLAND, Ore. -- AcryMed Inc., a medical device company specializing in wound care and infection control technology, today released research findings that show silver to be effective in combating methicillin-resistant Staphylococcus aureus (MRSA) topically, a potentially ...More
    July 12, 2005 Posted in News
  • Hospitals Cut Surgical Infection Rate by 27 Percent in One Year
    Fifty-six hospitals from 50 states and U.S. territories, collaborating to improve surgical care, significantly cut the rate of surgical infections for more than 35,000 patients in a year-long, nationwide effort sponsored by the federal Centers for Medicare & Medicare ...More
    June 24, 2005 Posted in News
  • Antibiotics Have Little Benefit for Uncomplicated Lower Respiratory Tract Infections
    Patients with uncomplicated lower respiratory tract infections, such as bronchitis, who were given antibiotics had little difference in symptom relief compared to patients who did not receive antibiotics, according to a study in JAMA. Acute lower respiratory tract illness ...More
    June 21, 2005 Posted in News
  • FDA Approves Tygacil, a Novel IV Antibiotic
    MADISON, N.J. -- The Food and Drug Administration (FDA) today approved Tygacil (tigecycline), a novel IV antibiotic with a broad spectrum of antimicrobial activity, including activity against the drug-resistant bacteria methicillin-resistant Staphylococcus aureus ...More
    June 16, 2005 Posted in News
  • Quickly Matching the Drug with the Bug Saves Lives
    University of Florida researchers are resurrecting an old technology to more quickly and accurately identify potentially deadly bacterial infections in hospital patients. Speed in identifying these bugs is crucial because bacteria such as E. coli can enter a patient's ...More
    June 13, 2005 Posted in News